Polynucleotides vs PRP for Hair Loss: Which Is Better in 2025?

Written by Rahena, Level 7 Aesthetic Practitioner | Mesglo London

Hair loss is a common concern affecting millions worldwide, impacting self-esteem and quality of life. As regenerative medicine advances, two prominent treatments have emerged for stimulating hair growth: Polynucleotides (PDRN) and Platelet-Rich Plasma (PRP). At Mesglo Aesthetic Clinic Marylebone, London, we understand the importance of informed decisions when considering such treatments. This comprehensive guide will delve into the mechanisms, clinical evidence, practical considerations, and suitability of each, helping you understand which option might be superior for your specific needs.

Understanding Polynucleotides (PDRN) for Hair Loss

Mechanism of Action

Polynucleotides, often referred to as PDRN (Polydeoxyribonucleotide), are long-chain DNA polymers derived from salmon DNA, purified and sterilised for medical use. These natural biostimulators work at a cellular level to promote tissue repair and regeneration. When injected into the scalp, polynucleotides provide a rich source of deoxyribonucleotides, which are the building blocks for DNA and RNA synthesis. This process:

• Stimulates fibroblast activity, leading to increased collagen and elastin production.
• Enhances cellular metabolism and protein synthesis.
• Promotes angiogenesis (formation of new blood vessels), improving blood supply to hair follicles.
• Reduces inflammation and oxidative stress in the scalp, creating a healthier environment for hair growth.
• Activates dormant hair follicles and prolongs the anagen (growth) phase of the hair cycle.

The regenerative properties of polynucleotides make them a potent tool for revitalising compromised hair follicles and improving overall scalp health.

Clinical Evidence

Numerous studies have explored the efficacy of polynucleotides in treating various forms of alopecia, particularly androgenetic alopecia. Research indicates that PDRN can significantly increase hair density and thickness, reduce hair shedding, and improve scalp microcirculation. A systematic review published in the Journal of Cosmetic Dermatology highlighted the promising results of polynucleotide treatments, noting their ability to stimulate hair follicle activity and improve hair parameters with a favourable safety profile. The consistent composition and standardised manufacturing process of polynucleotides contribute to their predictable clinical outcomes.

Understanding Platelet-Rich Plasma (PRP) for Hair Loss

Mechanism of Action

Platelet-Rich Plasma (PRP) therapy involves drawing a small amount of the patient's own blood, which is then processed to concentrate the platelets. These platelets are rich in growth factors, cytokines, and other bioactive proteins essential for tissue repair and regeneration. When PRP is injected into the scalp, these growth factors are released, initiating a cascade of biological responses:

• Stimulation of hair follicle stem cells.
• Promotion of angiogenesis, enhancing nutrient and oxygen supply to follicles.
• Extension of the anagen phase of the hair cycle.
• Reduction of inflammation and apoptosis (programmed cell death) in hair follicles.

The underlying principle of PRP is to harness the body's natural healing capabilities to rejuvenate dormant or miniaturised hair follicles.

Clinical Evidence

PRP has gained considerable attention for its potential in hair restoration. While many patients report positive outcomes, the clinical evidence for PRP can be more variable compared to polynucleotides. This variability often stems from differences in PRP preparation protocols (e.g., centrifugation speed, number of spins, platelet concentration), which can significantly affect the quality and efficacy of the final product. Some studies demonstrate significant improvements in hair density and thickness, while others show more modest results. The lack of standardisation across PRP treatments means that outcomes can vary between clinics and even between sessions for the same patient.

Key Differences: Polynucleotides vs PRP

Choosing between polynucleotides and PRP requires a thorough understanding of their practical differences:

Number of Sessions

• Polynucleotides: Typically involve 3-4 initial sessions, spaced 2-4 weeks apart, followed by maintenance sessions every 6-12 months.
• PRP: Often requires 3-6 initial sessions, spaced 4-6 weeks apart, with maintenance sessions every 3-6 months.

Downtime

• Polynucleotides: Minimal downtime. Patients may experience mild redness, swelling, or bruising at the injection sites, usually resolving within 24-48 hours.
• PRP: Similar minimal downtime, with potential for mild redness, swelling, or bruising. Some patients might experience temporary tenderness of the scalp.

Cost Considerations

The cost of both treatments can vary based on the clinic's location, the practitioner's expertise, and the number of sessions required. Generally, both are considered premium treatments. Polynucleotide treatments at Mesglo Aesthetic Clinic Marylebone, London, offer a transparent pricing structure, reflecting the high-quality, standardised product used. PRP costs can fluctuate more due to the varying preparation methods and equipment involved.

Patient Suitability

• Polynucleotides: Ideal for patients seeking a consistent, evidence-based approach without the need for blood draws. It is suitable for various stages of hair thinning and for those looking for overall scalp health improvement. More information can be found on our Polynucleotide Hair Treatment London page.
• PRP: Suitable for patients who prefer an autologous (using their own blood) treatment and are comfortable with the blood draw process. Its efficacy can be more dependent on individual patient factors and the specific PRP preparation.

Why Polynucleotides May Offer a More Consistent Approach

While both polynucleotides and PRP aim to stimulate hair growth, polynucleotides often present a more consistent and evidence-based option. The key advantage lies in their standardised composition and manufacturing. Unlike PRP, where the concentration and quality of growth factors can vary significantly depending on the blood draw, processing technique, and individual patient's blood quality, polynucleotides provide a predictable and uniform product. This standardisation translates to more reliable clinical outcomes and a reduced risk of variability between treatments.

Furthermore, polynucleotide treatment eliminates the need for a blood draw, making the procedure less invasive and more comfortable for many patients. This can be a significant advantage for individuals who are apprehensive about needles or have difficulty with blood collection. The robust clinical evidence supporting polynucleotides, coupled with their consistent mechanism of action, positions them as a highly effective and dependable solution for hair loss.

For those exploring advanced hair restoration options, you might also be interested in learning about Exosome for Hair Loss London, another cutting-edge treatment available at our clinic.

Conclusion

Both Polynucleotides and PRP offer promising avenues for combating hair loss, each with its unique strengths. However, for patients seeking a treatment with a highly consistent, evidence-based mechanism of action and a simpler procedure that avoids blood draws, polynucleotides often emerge as the preferred choice. At Mesglo Aesthetic Clinic Marylebone, London, located at 10, Unit 4 Portman Square, Baker St, London W1H 6AZ, United Kingdom, we are dedicated to providing personalised and effective hair restoration solutions.

We encourage you to schedule a consultation with our experts to discuss your specific concerns and determine the most suitable treatment plan for you. Our team will provide a thorough assessment and guide you through the best options for achieving optimal hair health.

Frequently Asked Questions

Q: Are polynucleotide treatments painful?

A: Most patients report minimal discomfort during polynucleotide injections. A topical anaesthetic can be applied to the scalp beforehand to ensure a more comfortable experience. The needles used are very fine, and the procedure is generally well-tolerated.

Q: How long does it take to see results from polynucleotide treatment?

A: While individual results may vary, patients typically begin to notice improvements in hair texture and reduced shedding within 1-2 months. Significant increases in hair density and growth are usually observed after 3-4 sessions, with optimal results appearing a few months after the full initial course.

Q: Is PRP therapy safe?

A: Yes, PRP therapy is generally considered safe as it uses the patient's own blood, minimising the risk of allergic reactions or transmissible diseases. Common side effects are mild and temporary, including redness, swelling, and bruising at the injection sites.

Q: Can polynucleotides and PRP be combined?

A: In some cases, practitioners may suggest combining different regenerative treatments to enhance results, depending on the patient's specific condition and goals. This should always be discussed and planned with a qualified medical professional.

Q: Who is an ideal candidate for polynucleotide hair treatment?

A: Ideal candidates are individuals experiencing early to moderate hair thinning, androgenetic alopecia, or those looking to improve overall scalp health and hair quality. A consultation at Mesglo Aesthetic Clinic Marylebone, London, will help determine your suitability.

For those seeking a comprehensive approach to hair restoration, scalp mesotherapy can complement polynucleotide or PRP therapy by delivering targeted nutrients and growth factors directly to the follicles. Ready to explore your hair restoration options? Book a consultation with Mesglo Aesthetic Clinic Marylebone, London today.

Book a consultation at Mesglo London to discuss this treatment.

View our before and after results to see real patient outcomes.

Browse all articles on the Mesglo London blog for more expert insights.